# Guangzhou REDPINE Medical Instrument Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-redpine-medical-instrument-co

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.gzredpine.com
- Total disclosed funding: $45M
- Latest round: Series D (Jul 30, 2024)
- Investors on record: 12

## About

Based in Guangzhou, China, and established in 2015, Guangzhou REDPINE Medical Instrument Co., Ltd. is a medical equipment provider that focuses on the research and development, and production of single-use Class III MIS devices, with a GMP factory and standard development and production line for endoscopes. In July 2024, the firm closed a series D funding. As of 2024, the company has obtained 50 overseas registration certificates including CE and FDA.

The company engages in providing disposable endoscopes and minimally invasive surgery solutions. The main products include single-use flexible video cystoscopes, image processors, biopsy forceps, single-use cystoscopes, and grasping forceps. The company's product planning covers urology, gynecology, ENT, respiratory and general surgery, etc. Its products are sold in Europe, the Middle East, North America, South America and other regions.

The company’s revenue is generated by providing cystoscopes, ureteroscopes, etc.

The company will use the series D funding for the iteration of multiple lens products and in-depth overseas business expansion. It will also continue to promote the construction of smart endoscopic operating rooms.

## Funding rounds

- Series D, Jul 30, 2024 — Oriza Holdings, China International Capital Corporation, Yuexiu Industrial Investment Funds Management, Suzhou Trust, Guangzhou Industry Investment Holding Group, Barley Capital, Beijing Huaxintong Yingchuang Investment Management
- Series C, Dec 9, 2022, $14M — Yuexiu Industrial Investment Funds Management, Guangzhou Guoju Venture Capital
- Series B, Oct 1, 2021, $15M — Hong Shan, Eight Roads Ventures, Tencent Investment, Taijiashan Health Industry Equity Investment Fund (Shanghai) Partnership
- Series A, Dec 21, 2020, $15M — Eight Roads Ventures, Oriza Holdings
- Angel, May 10, 2018 — Oriza Holdings

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Angel, Series A, Series D
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A, Series B
- Hong Shan — Series B
- Tencent Investment — Series B
- Taijiashan Health Industry Equity Investment Fund (Shanghai) Partnership — Series B
- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series C, Series D
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Series C
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D
- Suzhou Trust — Series D
- Guangzhou Industry Investment Holding Group (https://capitalatlas.ai/funds/guangzhou-industry-investment-holding-group) — Series D
- Barley Capital (https://capitalatlas.ai/funds/barley-capital) — Series D
- Beijing Huaxintong Yingchuang Investment Management (https://capitalatlas.ai/funds/beijing-huaxintong-yingchuang-investment-management) — Series D